BMC Cancer

official impact factor 3.15

Open Access Highly Access Email this article to a friend

Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) – phase I/II trial: study protocol

Stephanie E Combs*, Steffen Heeger, Renate Haselmann, Lutz Edler, Jürgen Debus and Daniela Schulz-Ertner

BMC Cancer 2006, 6:133 doi:10.1186/1471-2407-6-133

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.